|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Collaborative research and development fee | |||||
| Amortization of intangible assets | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest expense | |||||
| Loss on extinguishment of debt | |||||
| Income from equity investments | |||||
| Other income, net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Basic net income per share (in usd per share) | |||||
| Shares used to compute basic net income per share (in shares) | |||||
| Diluted net income per share (in usd per share) | |||||
| Shares used to compute diluted net income per share (in shares) |
Loading...
